Sponsors / SRRK
SRRK

Scholar Rock, Inc.

Company identity has not yet been verified

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
6Trials in this database
1Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular AtrophyNCT03921528Scholar Rock, Inc.Phase 2Completed2021-01-19Actual
Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or RisdiplamNCT05156320Scholar Rock, Inc.Phase 3Completed2024-12-18Actual
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of ApitegromabNCT05626855Scholar Rock, Inc.Phase 3Active not recruiting2026-11-01Estimated
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or ObeseNCT06445075Scholar Rock, Inc.Phase 2Completed2025-03-04Actual
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular AtrophyNCT07047144Scholar Rock, Inc.Phase 2Recruiting2028-11Estimated
Phase 2 Study Evaluating Apitegromab for the Treatment of FSHDNCT07435129Scholar Rock, Inc.Phase 2Recruiting2028-06Estimated

Latest recorded trial changes